Spectrofluorimetric determination of fluvoxamine in dosage forms and plasma via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole

Journal of Fluorescence

Volumn 19, Issue 3, 2009, Pages 463-471

  Darwish, Ibrahim A ^a   Amer, Sawsan M ^a   Abdine, Heba H ^a   Al Rayes, Lama I ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Fluvoxamine; NBD Cl; Pharmaceutical analysis; Spectroflourimetry

Indexed keywords

ALKALINE MEDIUM; DERIVATIZATION; DOSAGE FORMS; FLUORESCENCE INTENSITIES; FLUVOXAMINE; GOOD CORRELATIONS; HIGH SENSITIVITY; HIGHLY SENSITIVE; LIMITS OF DETECTION AND QUANTITATION; LINEAR RELATIONSHIPS; NBD-CL; NUCLEOPHILIC SUBSTITUTION REACTIONS; OPTIMIZED CONDITIONS; PHARMACEUTICAL ANALYSIS; PHARMACEUTICAL TABLETS; REACTION MECHANISM; RELATIVE STANDARD DEVIATIONS; SPECTROFLOURIMETRY; SPECTROFLUORIMETRIC DETERMINATION; SPECTROFLUORIMETRIC METHODS; SPIKED HUMAN PLASMAS;

FLUORESCENCE; PLASMAS; QUALITY ASSURANCE; QUALITY FUNCTION DEPLOYMENT; REACTION KINETICS; SUBSTITUTION REACTIONS; TOTAL QUALITY MANAGEMENT;

QUALITY CONTROL;

4 CHLORO 7 NITROBENZOFURAZAN; ANTIDEPRESSANT AGENT; FLUVOXAMINE; HYDROCHLORIC ACID; SOLVENT;

ARTICLE; BLOOD; CALIBRATION; CHEMISTRY; HUMAN; KINETICS; PH; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPECTROFLUOROMETRY; TEMPERATURE; TIME;

4-CHLORO-7-NITROBENZOFURAZAN; ANTIDEPRESSIVE AGENTS; CALIBRATION; FLUVOXAMINE; HUMANS; HYDROCHLORIC ACID; HYDROGEN-ION CONCENTRATION; KINETICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLVENTS; SPECTROMETRY, FLUORESCENCE; TEMPERATURE; TIME FACTORS;

EID: 67349104884     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-008-0433-z     Document Type: Article

References (32)

1. Potter WZ, Hollister LE (2004) In: Katzung BG (ed) Basic & clinical pharmacology, 9th edn.482-496
2. Iversen L, Glennon RA (2003) In: Abraham DJ (ed) Burger's medicinal chemistry and drug discovery, vol. 6,. 6th edn. Wiley, New York, p 483
3. British Pharmacopoeia (2003) The Stationary Office Ltd., London, pp 820-821
4. HP Nouws C Delerue-Matos AA Barros JA Rodrigues A Santos-Silva 2005 Electroanalytical study of fluvoxamine Anal Bioanal Chem 382 1662 1668 (Pubitemid 41090475)
5. S Trefi V Gilard S Balayssac M Malet-Martino R Martino 2008 Quality assessment of fluoxetine and fluvoxamine pharmaceutical formulations purchased in different countries or via the internet by 19F and 2D DOSY 1H NMR J Pharm Biomed Anal 46 707 722
6. The United States Pharmacopeia 31, The National Formulary 26 (2008) US Pharmacopeial Convention Inc., Rockville MD, pp. 2225-2227
7. AS Maria M Laura F Giuseppina JA Lawrence M Roberto AR Maria 2006 Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography J Chromatogr B Analyt Technol Biomed Life Sci 843 227 233
8. T Ohkubo R Shimoyama K Otani K Yoshida H Higuchi T Shimizu 2003 High-performance liquid chromatographic determination of fluvoxamine and fluvoxamino acid in human plasma Anal Sci 19 859 864
9. JJ Berzas MJ Villaseñor C Guiberteau V Rodríguez S Buitrago 2006 Sensitive capillary GC-MS-SIM determination of selective serotonin reuptake inhibitors: reliability evaluation by validation and robustness study J Sep Sci 29 103 113 (Pubitemid 43203194)
10. JJ Berzas MJ Villaseñor AM Conten o E Agua 2005 Assay validation for three antidepressants in pharmaceutical formulations: practical approach using capillary gas chromatography J Pharm Biomed Anal 38 52 59
11. JJ Berzas MJ Villaseñor AM Contento E Agua 2000 Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography J Chromatogr Sci 38 200 206
12. JJ Berzas AM Contento MJ Villaseñor E Aguas 2000 Method development and validation for the simultaneous determination of fluoxetine and fluvoxamine in pharmaceutical preparations by capillary electrophoresis Anal Chim Acta 417 169 176
13. AA Alhaider ME Hagga ME Alawady EA Gad-kariem 1993 Spectrophotometric determination of fluvoxamine in tablets based on charge-transfer complex with chloranil Anal Lett 26 887 901
14. B Starczewska A Jasińska B Białous 2003 Study and analytical application of ion-pair formation in the system fluoxetine- pyrocatechol violet and fluvoxamine-pyrocatechol violet Pharmazie 58 245 248 (Pubitemid 36512786)
15. B Starczewska K Mielech 2000 Application of chrome azurol S for the extractive spectrophotometric determination of fluoxetine and fluvoxamine J Pharm Biomed Anal 23 243 247 (Pubitemid 30599437)
16. S Atmaca S Tarta 1994 Spectrophotometric determination of fluvoxamine maleate in tablets Pharmazie 49 458 459 (Pubitemid 24203000)
17. B Starczewska H Puzanowska-Tarasiewicz K Baranowska 2000 Investigation and analytical application of the reactions of eriochrome cyanine R with fluvoxamine and fluoxetine J Pharm Biomed Anal 23 477 481 (Pubitemid 30599462)
18. IA Darwish IH Refaat 2006 Spectrophotometric analysis of selective serotonin reuptake inhibitors based on formation of charge-transfer complexes with tetracyano-quinodimethane and chloranilic acid J AOAC Int 89 326 333 (Pubitemid 46002962)
19. N El-Enany 2007 Spectrofl orometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamine J AOAC Int 90 376 383 (Pubitemid 350067235)
20. EA Taha NN Salama L Fattah 2006 Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl) Chem Pharm Bull (Tokyo) 54 653 658
21. N El-Enany D El-Sherbiny F Belal 2007 Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage forms and human plasma Chem Pharm Bull (Tokyo) 55 1662 1670 (Pubitemid 350232535)
22. HM Saleh MM El-Henawee GH Ragab SS El-Hay 2007 Utility of NBD-Cl for the spectrophotometric determination of some skeletal muscle relaxant and antihistaminic drugs Spectrochim. Acta [A] 67 1284 1289 (Pubitemid 47017771)
23. RO Olojo RH Xia JJ Abramson 2005 Spectrophotometric and fluorometric assay of superoxide ion using 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole Anal Biochem 339 338 344 (Pubitemid 40395292)
24. Pesez M, Bartos J (1974) Colorimetric and spectrofluorimetric analysis of organic compounds and drugs. Marcel Dekker Inc., New York, pp 628-630
25. Rose J (1964) In: Advanced physicochemical experiments. Pitman, London, p 67
26. ES Aktas L Ersoy O Sagirh 2003 A new spectrofluorimetric method for the determination of lisinopril in tablets IL Farmaco 58 165 168 (Pubitemid 36197653)
27. H Miyano T Toyo'oka K Imai 1985 Further studies on the reaction of amines and proteins with 4-fluoro-7-nitrobenzo-2-oxa-1,3-diazole Anal Chim Acta 170 81 87
28. K Imai T Toyo Oka H Miyano 1984 Fluorigenic reagents for primary and secondary amines and thiols in high-performance liquid chromatography. A review Analyst (Lond) 109 1365 1373
29. Martin A, Swarbrick J, Cammarata A, Chun A (2004) Physical pharmacy: physical chemical principles in the pharmaceutical sciences, 3rd edn. Lea & Febiger, Philadel hia, p 371
30. ICH guideline Q2(R1) (2005) Validation of analytical procedures: text and methodology, London
31. AK Banerjee 1988 BMJ 296 1774
32. ST Ulu 2007 HPLC method for the determination of fluvoxamine in human plasma and urine for application to pharmacokinetic studies J Pharm Biomed Anal 43 1444 1451 (Pubitemid 46282385)